NYSE: UBSUbs Group Ag Stock
$30.23-0.28 (-0.92%)
Updated Apr 30, 2025
UBS Price
$30.23
Fair Value Price
N/A
Market Cap
$95.97B
52 Week Low
$25.75
52 Week High
$35.84
P/E
17.11x
P/B
1.02x
P/S
1.8x
PEG
0.62x
Dividend Yield
N/A
Revenue
$54.01B
Earnings
$5.65B
Gross Margin
100%
Operating Margin
13.91%
Profit Margin
10.5%
Debt to Equity
17.39
Operating Cash Flow
$4B
Beta
1.03
Next Earnings
May 5, 2025
Ex-Dividend
N/A
Next Dividend
N/A
UBS Overview
UBS Group AG is a multinational investment bank and financial services company. It provides advice and solutions to private, institutional, and corporate clients in the U.S. and internationally. UBS Group AG was founded in 1862 and is based in Zurich, Switzerland.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine UBS's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Diversified Bank
Industry Rating
F
UBS
Ranked#19 of 20
Ranked#19 of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $16.06 | B | |
| $12.92 | C | |
| $40.18 | C |
Be the first to know about important UBS news, forecast changes, insider trades & much more!
UBS News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how UBS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
UBS ($30.23) is trading above its intrinsic value of $27.49, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
UBS is good value based on its earnings relative to its share price (17.11x), compared to the US market average (29.18x)
P/E vs Market Valuation
UBS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more UBS due diligence checks available for Premium users.
Valuation
UBS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
17.11x
Industry
12.63x
Market
29.18x
UBS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
UBS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
UBS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.02x
Industry
1.23x
UBS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
UBS price to earnings growth (PEG)
For valuing profitable companies with growth potential
UBS is good value based... subscribe to Premium to read more.
PEG Value Valuation
UBS's financial health
Profit margin
Revenue
$54.0B
Net Income
$5.7B
Profit Margin
10.5%
UBS's Earnings (EBIT) of $7.51B... subscribe to Premium to read more.
Interest Coverage Financials
UBS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$1.7T
Liabilities
$1.6T
Debt to equity
17.39
UBS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
UBS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$3.6B
Investing
$787.8M
Financing
-$93.5B
UBS's operating cash flow ($3.64B)... subscribe to Premium to read more.
Debt Coverage Financials
UBS vs Diversified Bank Stocks
Ubs Group Ag Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.